Discover 884 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 884
The Effect of the Menstrual Cycle on Immune Cell Activity and Recovery After Resistance Exercise
for
Healthy Women, Menstruation, Resistance Exercise
Location: Orlando FL
Sponsor: University of Central Florida
Sex: Female
Age: 18 - 40
Code: NCT06985420
Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
for
Myasthenia Gravis
Location: Maitland FL, Clearwater FL, Greenville SC, New Bern NC,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07673744
Phase 2, Recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Maitland FL, Little Rock AR, Avon Lake OH, Houston TX,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06786624
Phase 3, Recruiting
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
for
Schizophrenia
Location: Maitland FL, Tampa FL, West Palm Beach FL, Miami FL,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18 - 65
Code: NCT07227818
Phase 3, Recruiting
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
for
Schizophrenia
Location: Maitland FL, Tampa FL, West Palm Beach FL, Atlantis FL,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18 - 65
Code: NCT07114874
Phase 3, Recruiting
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Maitland FL, Miami FL, Charlotte NC, Cedarhurst NY,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06963021
Phase 3, Recruiting
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment